Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis
Abstract There are limited therapeutic methods for triple negative breast cancer in the clinic, which is easy to progress into the brain to form metastatic lesions and evolve into the terminal stage. Because both the primary cancer and the brain metastasis have high glycolysis, we hypothesize that l...
Enregistré dans:
Auteurs principaux: | Tieying Dong, Zhaoliang Liu, Qijia Xuan, Zhuozhong Wang, Wenjie Ma, Qingyuan Zhang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/18d8357cacd34779a33c7e8abce0070c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications
par: Mona Ebadi, et autres
Publié: (2020) -
Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
par: Wen-Hung Kuo, et autres
Publié: (2012) -
Study of the effect of the LDH cations precursors in the removal of arsenic in aqueous solution
par: María Martha Barroso Quiroga, et autres
Publié: (2021) -
Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models
par: Megan C. Cox, et autres
Publié: (2021) -
High-efficiency CO2 separation using hybrid LDH-polymer membranes
par: Xiaozhi Xu, et autres
Publié: (2021)